Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
PNU 142300-13C1,d2 is derived from (R)-Benzyl (2-((tert-Butyldimethylsilyl)oxy)ethyl)(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)carbamate (B700010), which s an intermediate in the synthesis of PNU 142586 Sodium Salt, which is an inactive metabolite of Linezolid (L466500).